Blog

EXOSYSTEMS’ exoRehab Named a CES Innovation Awards 2026 Honoree in Digital Health

AI-powered wearable brings clinic-grade muscle tracking to at-home rehab. Live demos Jan. 6–9 at CES 2026.…

Dr Lal PathLabs launches Sovaaka diagnostic experience centre in Gurugram – Express Healthcare

Dr Lal PathLabs announced the launch of Sovaaka, a Diagnostic Experience Centre, in Gurugram. The launch…

5 Trends in Medical Tourism in 2026 – Express Healthcare

Rajeev Taneja, Founder, GlobalCare Health, highlights key trends shaping medical tourism in 2026 Rajeev Taneja, Founder,…

Older Americans Quit Weight-Loss Drugs in Droves – KFF Health News

Year after year, Mary Bucklew strategized with a nurse practitioner about losing weight. “We tried exercise,”…

How physician coaching helps restore energy reserves

I’ve recently been intrigued by this question: Are you giving from extra or essence? In many…

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Covenant Health, Inc. Customers Whose Data May Have Been Compromised

NEWTOWN, Pa., Jan. 3, 2026 /PRNewswire/ — The law firm ofEdelson Lechtzin LLP is investigating data…

Physician investment in patients: ethical risks and rewards

SAN FRANCISCO, Jan. 4, 2026 /PRNewswire/ –The INSIDE Institute for NeuroAI has demonstrated that non-invasive brain–computer…

Brain Signal-Based Control Moves Beyond the Lab as INSIDE Institute Demonstrates Real-World Non-Invasive BCI Breakthroughs

SAN FRANCISCO, Jan. 4, 2026 /PRNewswire/ –The INSIDE Institute for NeuroAI has demonstrated that non-invasive brain–computer…

Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis

Elanco’s second dermatology product approval in less than 18 months in the estimated $1.3 billion U.S.…

Physicians' end-of-life choices: a surprising study

–The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to…